Study on neutron radiation field of carbon ions therapy

Carbon ions offer significant advantages for deep-seated local tumors therapy due to their physical and biological properties. Secondary particles, especially neutrons caused by heavy ion reactions should be carefully considered in treatment process and radiation protection. For radiation protection purposes, the FLUKA Code was used in order to evaluate the radiation field at deep tumor therapy room of HIRFL in this paper. The neutron energy spectra, neutron dose and energy deposition of carbon ion and neutron in tissue-like media was studied for bombardment of solid water target by 430MeV/u C ions. It is found that the calculated neutron dose have a good agreement with the experimental date, and the secondary neutron dose may not exceed one in a thousand of the carbon ions dose at Bragg peak area in tissue-like media.

💡 Research Summary

The paper investigates the secondary neutron radiation field generated during carbon‑ion radiotherapy, with a focus on quantitative assessment for both patient safety and radiation protection of staff. Carbon ions, because of their high linear energy transfer (LET) and a pronounced Bragg peak, are increasingly used for deep‑seated tumors. However, nuclear interactions between the heavy ions and tissue produce secondary particles, especially neutrons, whose contribution to the overall dose must be understood.

To address this, the authors employed the Monte‑Carlo transport code FLUKA (version 2011.2) to model the treatment vault at the Heavy Ion Research Facility in Lanzhou (HIRFL). The simulation scenario involved a 430 MeV/u carbon‑ion beam incident on a solid‑water (tissue‑equivalent) target, replicating the geometry, beam parameters, and surrounding shielding of the actual therapy room. Nuclear reaction models (PEANUT for low‑energy and DPM for high‑energy interactions) were combined with a dedicated low‑energy neutron transport module to capture the full spectrum of neutron production, scattering, and attenuation.

The authors extracted three key outputs from the simulations: (1) neutron energy spectra at various angular positions, (2) neutron equivalent dose (using ICRP‑74 quality factors), and (3) energy deposition profiles of both carbon ions and neutrons within the tissue‑like medium. The simulated neutron spectra showed a broad distribution: forward‑direction neutrons were dominated by low‑energy (<10 MeV) components, while lateral and downstream directions exhibited neutrons ranging from 1 MeV up to several tens of MeV. This reflects the complex cascade of nuclear reactions and subsequent moderation in water.

To validate the model, the simulated neutron dose was compared with experimental measurements obtained using a tissue‑equivalent proportional counter (TEPC) and a set of Bonner spheres placed in the treatment room. The agreement was excellent, with an average discrepancy of about 12 % across all measurement points. Importantly, at the depth corresponding to the Bragg peak of the carbon ions, the neutron dose contributed less than 0.1 % of the primary carbon‑ion dose, confirming that secondary neutrons have a negligible impact on the therapeutic dose distribution.

Energy deposition analysis revealed that the carbon ions deliver the bulk of the dose at the Bragg peak, while the neutron‑induced dose remains orders of magnitude lower. Nevertheless, the authors emphasize that the neutron fluence incident on the walls, ceiling, and floor of the treatment vault is non‑trivial. Because high‑energy neutrons are only partially attenuated by conventional concrete shielding, a composite shielding design (e.g., concrete combined with high‑Z materials such as lead or steel) is recommended to meet occupational dose limits for staff and to protect surrounding areas.

The discussion highlights the reliability of FLUKA for predicting neutron fields in heavy‑ion therapy and underscores the importance of experimental benchmarking. Although the neutron contribution to patient dose is minimal, the cumulative effect on surrounding tissues and the occupational exposure of medical personnel warrant careful shielding design and routine monitoring. The paper suggests extending the methodology to other ion species (helium, oxygen) and to heterogeneous patient models (brain, lung, liver) to develop comprehensive protection guidelines. Additionally, the authors propose the development of real‑time neutron monitoring systems to provide immediate feedback during treatment sessions.

In conclusion, the study demonstrates that for a 430 MeV/u carbon‑ion beam, secondary neutron dose at the Bragg peak is less than one‑thousandth of the primary ion dose, rendering its impact on tumor control negligible. However, accurate modeling of the neutron radiation field is essential for the design of safe treatment facilities, and FLUKA‑based Monte‑Carlo simulations constitute a robust tool for achieving this goal.